Growth Metrics

Strata Critical Medical (SRTA) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to $0.7.

  • Strata Critical Medical's EPS (Weighted Average and Diluted) rose 110000.0% to $0.7 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.49, marking a year-over-year increase of 16621.62%. This contributed to the annual value of -$0.35 for FY2024, which is 5363.8% up from last year.
  • Latest data reveals that Strata Critical Medical reported EPS (Weighted Average and Diluted) of $0.7 as of Q3 2025, which was up 110000.0% from -$0.05 recorded in Q2 2025.
  • Over the past 5 years, Strata Critical Medical's EPS (Weighted Average and Diluted) peaked at $0.7 during Q3 2025, and registered a low of -$0.47 during Q2 2021.
  • In the last 5 years, Strata Critical Medical's EPS (Weighted Average and Diluted) had a median value of -$0.14 in 2023 and averaged -$0.1.
  • Per our database at Business Quant, Strata Critical Medical's EPS (Weighted Average and Diluted) tumbled by 529076.41% in 2021 and then soared by 110000.0% in 2025.
  • Quarter analysis of 5 years shows Strata Critical Medical's EPS (Weighted Average and Diluted) stood at $0.01 in 2021, then crashed by 2263.87% to -$0.22 in 2022, then plummeted by 112.58% to -$0.46 in 2023, then soared by 47.89% to -$0.24 in 2024, then soared by 392.04% to $0.7 in 2025.
  • Its last three reported values are $0.7 in Q3 2025, -$0.05 for Q2 2025, and -$0.04 during Q1 2025.